QSAR STUDY OF HCV NS5B POLYMERASE INHIBITORS USING THE GENETIC ALGORITHM-MULTIPLE LINEAR REGRESSION (GA-MLR)

被引:0
|
作者
Rafiei, Hamid [1 ]
Khanzadeh, Marziyeh [2 ]
Mozaffari, Shahla [2 ]
Bostanifar, Mohammad Hassan [1 ]
Avval, Zhila Mohajeri [2 ]
Aalizadeh, Reza [3 ]
Pourbasheer, Eslam [2 ]
机构
[1] Islamic Azad Univ, Dashtestan Branch, Dept Chem, Dashtestan, Iran
[2] PNU, Dept Chem, POB 19395-3697, Tehran, Iran
[3] Univ Athens, Dept Chem, Analyt Chem Lab, Athens 15771, Greece
来源
EXCLI JOURNAL | 2016年 / 15卷
关键词
QSAR; Genetic algorithms; Multiple linear regression; HCV; HEPATITIS-C; RNA-POLYMERASE; IDENTIFICATION; ANTAGONISTS; PREVENTION; PREDICTION; STRATEGY; THERAPY; INDEXES;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Quantitative structure-activity relationship (QSAR) study has been employed for predicting the inhibitory activities of the Hepatitis C virus (HCV) NS5B polymerase inhibitors. A data set consisted of 72 compounds was selected, and then different types of molecular descriptors were calculated. The whole data set was split into a training set (80 % of the dataset) and a test set (20 % of the dataset) using principle component analysis. The stepwise (SW) and the genetic algorithm (GA) techniques were used as variable selection tools. Multiple linear regression method was then used to linearly correlate the selected descriptors with inhibitory activities. Several validation technique including leave-one-out and leave-group-out cross-validation, Y-randomization method were used to evaluate the internal capability of the derived models. The external prediction ability of the derived models was further analyzed using modified r(2), concordance correlation coefficient values and Golbraikh and Tropsha acceptable model criteria's. Based on the derived results (GA-MLR), some new insights toward molecular structural requirements for obtaining better inhibitory activity were obtained.
引用
收藏
页码:38 / 53
页数:16
相关论文
共 50 条
  • [11] HCV NS5B Polymerase Inhibitors
    Burton, James R., Jr.
    Everson, Gregory T.
    CLINICS IN LIVER DISEASE, 2009, 13 (03) : 453 - +
  • [12] QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine
    Pourbasheer, Eslam
    Riahi, Siavash
    Ganjali, Mohammad Reza
    Norouzi, Parviz
    MOLECULAR DIVERSITY, 2011, 15 (03) : 645 - 653
  • [13] Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking Study
    Elfiky, Abdo A.
    MEDICINAL CHEMISTRY, 2019, 15 (02) : 130 - 137
  • [14] QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine
    Eslam Pourbasheer
    Siavash Riahi
    Mohammad Reza Ganjali
    Parviz Norouzi
    Molecular Diversity, 2011, 15 : 645 - 653
  • [15] HCV Non-Nucleoside NS5B Polymerase Inhibitors
    Wu Daochun
    He Yanping
    PROGRESS IN CHEMISTRY, 2012, 24 (11) : 2255 - 2267
  • [16] Modelling the Anticancer Activity of 4-Alkoxy Cinnamic Analogues using 3D-Descriptors and Genetic Algorithm-Multiple Linear Regression (GA-MLR) Method
    Rasyid, Herlina
    Soekamto, Nunuk Hariani
    Seniwati
    Firdausiah, Syadza
    Firdaus
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2023, 35 (03)
  • [17] 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase
    McGowan, David
    Nyanguile, Origene
    Cummings, Maxwell D.
    Vendeville, Sandrine
    Vandyck, Koen
    Van den Broeck, Walter
    Boutton, Carlo W.
    De Bondt, Hendrik
    Quirynen, Ludo
    Amssoms, Katie
    Bonfanti, Jean-Francois
    Last, Stefaan
    Rombauts, Klara
    Tahri, Abdellah
    Hu, Lili
    Delouvroy, Frederic
    Vermeiren, Katrien
    Vandercruyssen, Genevieve
    Van der Helm, Liesbet
    Cleiren, Erna
    Mostmans, Wendy
    Lory, Pedro
    Pille, Geert
    Van Emelen, Kristof
    Fanning, Gregory
    Pauwels, Frederik
    Lin, Tse-I
    Simmen, Kenneth
    Raboisson, Pierre
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) : 2492 - 2496
  • [18] Evaluation of Coumarin and Neoflavone Derivatives as HCV NS5B Polymerase Inhibitors
    Nichols, Daniel B.
    Leao, Raquel A. C.
    Basu, Amartya
    Chudayeu, Maksim
    de Moraes, Paula de F.
    Talele, Tanaji T.
    Costa, Paulo R. R.
    Kaushik-Basu, Neerja
    CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 81 (05) : 607 - 614
  • [19] DISCOVERY OF NOVEL HCV NS5B POLYMERASE INHIBITORS BY IN SILICO APPROACHES
    Karaman Mayack, Berin
    JOURNAL OF RESEARCH IN PHARMACY, 2023, 27 : 13 - 15
  • [20] The activity prediction of indole inhibitors against HCV NS5B polymerase
    Muhire, Jules
    Zhai, Hong Lin
    Lu, Shao Hua
    Li, Sha Sha
    Yin, Bo
    Mi, Jia Ying
    CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 95 (02) : 240 - 247